MTOR and acute lymphoblastic leukemia: The activation of AKT and MTOR signaling also plays a critical role in steroid resistance in ALL (55, 56), and multiple agents targeting the PI3K/AKT/MTOR axis are currently in clinical trials for pediatric ALL [reviewed in Ref.